Safety and BNT162b2 mRNA COVID-19 vaccination

Safety and BNT162b2 mRNA COVID-19 vaccination

Authors

  • Beuy Joob Sanitation 1 Academic Center, Bangkok, Thailand
  • Viroj Wiwanitkit Honorary professor, Dr DY Patil University, Pune, India

Keywords:

safety, covid, vaccine

Abstract

n/a

References

Vigezzi GP, Lume A, Minerva M, Nizzero P, Biancardi A, Gianfredi V, Odone A, Signorelli C, Moro M. Safety surveillance after BNT162b2 mRNA COVID-19 vaccination: results from a cross-sectional survey among staff of a large Italian teaching hospital. Acta Biomed [Internet]. 2021 Oct. 1 [cited 2021 Oct. 4];92(S6):e2021450.

Mishra S, Mungmunpuntipantip I. Editorial: a good case report that might not be accepted for publication in a journal. Case Study Case Rep. 2021; 11(3): 32 - 33.

Downloads

Published

19-01-2022

Issue

Section

E-LETTERS: COMMENTS AND RESPONSES

How to Cite

1.
Joob B, Wiwanitkit V. Safety and BNT162b2 mRNA COVID-19 vaccination. Acta Biomed [Internet]. 2022 Jan. 19 [cited 2024 Jul. 13];92(6):e2021485. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/12359